How much is Climb Bio worth in 2026?

Climb Bio has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Climb Bio raised?

Climb Bio has raised N/A in total funding across 1 funding rounds.

Climb Bio

Drug Discovery

Climb Bio valuation and funding history | Last updated: June 27, 2024 | 1 funding rounds

Current Valuation

N/A

As of June 27, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$120.0M

Last Funding

Jun 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
June 27, 2024	PIPE	$120.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Climb Bio is currently valued at N/A as of June 27, 2024.

Track Climb Bio Valuation Updates

Get notified when Climb Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Climb Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Climb Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Climb Bio Worth in 2026?

Climb Bio is a leading private company in the Drug Discovery sector. Track Climb Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Climb Bio Valuation is Determined

Private company valuations like Climb Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.